Blood Group Typing Market Analysis

Blood Group Typing Market Analysis

In terms of the type of components, the blood group typing market share from the instruments segment is anticipated to witness a CAGR of over 9% through 2022-2030. Instruments such as the automated blood grouping machine are used to identify the blood type of an individual by performing a wide variety of tests, such as Rh typing, cross-matching, ABO grouping, and antibody screening. With an increasing number of road accidents and trauma-inducing incidents reported worldwide, the use of blood group typing instruments is expected to soar across healthcare settings.

To get key market trends

  Download Free Sample

Based on the type of technique, the blood group typing market is classified into assay-based, next-generation sequencing (NGS), PCR-based & microarray, and others. PCR-based & microarray segment is projected to generate more than USD 1 billion by 2030. The process has widespread application during the screening of rare blood types. High prevalence of chronic conditions such as sickle cell anemia, and leukemia, among others, is anticipated to boost the segment outlook. The Center for Disease Control and Prevention (CDC) estimates that sickle cell anemia or sickle cell disease (SCD) affects nearly 100,000 Americans.
 

Blood group typing market from antigen typing segment accounted for more than 20% business share in 2021. This type of testing helps medical professionals to detect the presence or absence of corresponding antibodies in patients. The technique is often applied to individuals that need long-term transfusion therapies, helping practitioners to gain insight into the phenotypically compatible units. With the rising prevalence of infectious diseases, the application of antigen typing will gain momentum.
 

Blood group typing market from blood banks segment is anticipated to exceed USD 540 million by 2030. Over the last decade, the number of blood banks worldwide have increased significantly. For instance, according to the WHO, nearly 13,300 blood centers are spread across 169 countries and reported 106 million donations as of 2022. These centers are focusing on ramping up voluntary blood donations that will drive the need for blood group typing tests.
 

North America blood group typing market accounted for over 30% revenue share in 2021. The U.S. has a massive footprint of key industry players who are expanding their product portfolio. The presence of federal agencies such as the Food and Drug Administration (FDA) has enabled the commercialization of innovative blood group typing solutions.